Publications by the researcher in collaboration with Eva Poveda López (16)

2019

  1. Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain

    Open Forum Infectious Diseases, Vol. 6, Núm. 2

  2. HTLV testing of solid organ transplant donors

    Clinical Transplantation

  3. HTLV-1 infection in solid organ transplant donors and recipients in Spain

    BMC Infectious Diseases, Vol. 19, Núm. 1

2017

  1. Human T-Lymphotropic Virus Infection in Hepatitis C Virus-Antibody Positive Patients in Spain

    AIDS Research and Human Retroviruses, Vol. 33, Núm. 10, pp. 1013-1017

  2. Human T-lymphotropic virus type 1 infection and disease in Spain

    AIDS, Vol. 31, Núm. 12, pp. 1653-1663

2015

  1. Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults

    Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 104.e1-104.e5

  2. Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)

    Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 105.e1-105.e5

2014

  1. HIV-2 and HTLV-1 infections in Spain, a non-endemic region

    AIDS Reviews, Vol. 16, Núm. 3, pp. 152-159

  2. HIV-2 viral tropism influences CD4+ T cell count regardless of viral load

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 8, pp. 2191-2194

2013

  1. Hepatitis B, C, and D and HIV infections among immigrants from equatorial guinea living in Spain

    American Journal of Tropical Medicine and Hygiene, Vol. 88, Núm. 4, pp. 789-794

  2. Hepatitis C therapy with HCV NS5B polymerase inhibitors

    Expert Opinion on Pharmacotherapy, Vol. 14, Núm. 9, pp. 1161-1170

  3. Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C

    Antiviral Therapy, Vol. 18, Núm. 8, pp. 1033-1035

2011

  1. Highlights from the last international drug resistance workshop (June 2011)

    AIDS Reviews

  2. Natural polymorphisms associated with resistance to new antivirals against HCV in newly diagnosed HIV-HCV-coinfected patients

    Antiviral Therapy, Vol. 16, Núm. 3, pp. 413-416

2009

  1. Changes in drug resistance patterns following the introduction of HIV type 1 non-B subtypes in Spain

    AIDS Research and Human Retroviruses, Vol. 25, Núm. 10, pp. 967-972

2008

  1. Resistencia viral y barrera genética de atazanavir

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. SUPPL. 17, pp. 28-33